Gianluca Sorriento

Gianluca Sorriento is an experienced market access professional with a comprehensive background in pricing, reimbursement, and market access strategy across European and international markets. Currently serving as the Market Access Lead for Jazz Pharmaceuticals since January 2018, Gianluca is responsible for the PRMA strategy for haema-onco products and prioritizing goals to support product growth. Previous roles include Market Access Head and National Market Access Senior Manager in Italy, Market Access Director at Johnson & Johnson, and Institutional Projects Manager at the Biopharma Business of Merck. Gianluca's expertise also encompasses extensive experience in pharmacoeconomic activities and health technology assessment, with notable positions at Otsuka Pharmaceutical Italy, Celgene, and GSK. Gianluca holds advanced degrees in Pharmaeconomy and Health Economics, as well as a post-graduate diploma in Market Access, reflecting a robust academic foundation in the field.